Skip to main content
Top
Published in: Clinical Rheumatology 2/2016

01-02-2016 | Brief Report

Assessment of nailfold capillaries with a handheld dermatoscope may discriminate the extent of organ involvement in patients with systemic sclerosis

Authors: Juan C. Arana-Ruiz, Luis H. Silveira, Diana Castillo-Martínez, Luis M. Amezcua-Guerra

Published in: Clinical Rheumatology | Issue 2/2016

Login to get access

Abstract

To investigate whether nailfold capillaroscopy (NFC) patterns assessed through an in-office handheld dermatoscope may reflect the extent of disease severity in systemic sclerosis (SSc). NFC patterns were evaluated with a non-contact, polarized light dermatoscope in 40 consecutive patients with SSc and graded in sequence as 0 = normal, 1 = early, 2 = active, or 3 = late patterns. Disease severity was measured according to a modified Medsger severity scale (MSS). For comparisons, patients were grouped in tertiles according to disease severity, and a numerical correlation between the NFC patterns and the composite MSS score was assessed. Twenty patients had normal or early NFC patterns, most of them (17 individuals, 85 %) having low to moderate disease severity. In contrast, 18 out of 20 (90 %) patients with active or late NFC patterns had moderate to high disease severity. Accordingly, patients with normal/early NFC patterns had a median MSS score of 4 (interquartile range (IQR), 3–5) as compared with 7 (4–8; P = 0.02) in those with active/late patterns. A Spearman’s rho coefficient of 0.45 (95 % CI, 0.15–0.67; P = 0.003) was found between the graded scale of NFC patterns and the composite MSS score. A handheld dermatoscope is useful to visualize the NFC patterns in SSc patients, and it is efficient enough to reflect the extent of disease severity.
Literature
1.
go back to reference van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A et al (2013) 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum 65:2737–2747PubMedCentralCrossRefPubMed van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A et al (2013) 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum 65:2737–2747PubMedCentralCrossRefPubMed
2.
go back to reference Pope J (2011) Measures of systemic sclerosis (scleroderma). Arthritis Care Res 63:S98–S111CrossRef Pope J (2011) Measures of systemic sclerosis (scleroderma). Arthritis Care Res 63:S98–S111CrossRef
3.
go back to reference Cutolo M, Sulli A, Secchi ME, Paolino S, Pizzorni C (2006) Nailfold capillaroscopy is useful for the diagnosis and follow-up of autoimmune rheumatic diseases. A future tool for the analysis of microvascular heart involvement? Rheumatology 45(Suppl 4):iv43–iv46PubMed Cutolo M, Sulli A, Secchi ME, Paolino S, Pizzorni C (2006) Nailfold capillaroscopy is useful for the diagnosis and follow-up of autoimmune rheumatic diseases. A future tool for the analysis of microvascular heart involvement? Rheumatology 45(Suppl 4):iv43–iv46PubMed
4.
go back to reference Maricq HR, LeRoy EC (1973) Patterns of finger capillary abnormalities in connective tissue disease by “wide-field” microscopy. Arthritis Rheum 16:619–628CrossRefPubMed Maricq HR, LeRoy EC (1973) Patterns of finger capillary abnormalities in connective tissue disease by “wide-field” microscopy. Arthritis Rheum 16:619–628CrossRefPubMed
5.
go back to reference Cutolo M, Sulli A, Pizzorni C, Accardo S (2000) Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol 27:155–160PubMed Cutolo M, Sulli A, Pizzorni C, Accardo S (2000) Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol 27:155–160PubMed
6.
go back to reference Dogan S, Akdogan A, Atakan N (2013) Nailfold capillaroscopy in systemic sclerosis: is there any difference between videocapillaroscopy and dermatoscopy? Skin Res Technol 19:446–449PubMed Dogan S, Akdogan A, Atakan N (2013) Nailfold capillaroscopy in systemic sclerosis: is there any difference between videocapillaroscopy and dermatoscopy? Skin Res Technol 19:446–449PubMed
7.
go back to reference Hughes M, Moore T, O’Leary N, Tracey A, Ennis H, Dinsdale G et al (2015) A study comparing videocapillaroscopy and dermoscopy in the assessment of nailfold capillaries in patients with systemic sclerosis-spectrum disorders. Rheumatology 54:1435–1442CrossRefPubMed Hughes M, Moore T, O’Leary N, Tracey A, Ennis H, Dinsdale G et al (2015) A study comparing videocapillaroscopy and dermoscopy in the assessment of nailfold capillaries in patients with systemic sclerosis-spectrum disorders. Rheumatology 54:1435–1442CrossRefPubMed
8.
go back to reference Mazzotti NG, Bredemeier M, Brenol CV, Xavier RM, Cestari TF (2014) Assessment of nailfold capillaroscopy in systemic sclerosis by different optical magnification methods. Clin Exp Dermatol 39:135–141CrossRefPubMed Mazzotti NG, Bredemeier M, Brenol CV, Xavier RM, Cestari TF (2014) Assessment of nailfold capillaroscopy in systemic sclerosis by different optical magnification methods. Clin Exp Dermatol 39:135–141CrossRefPubMed
9.
go back to reference Marino Claverie L, Knobel E, Takashima L, Techera L, Oliver M, Gonzalez P et al (2013) Organ involvement in Argentinian systemic sclerosis patients with “late” pattern as compared to patients with “early/active” pattern by nailfold capillaroscopy. Clin Rheumatol 32:839–843CrossRefPubMed Marino Claverie L, Knobel E, Takashima L, Techera L, Oliver M, Gonzalez P et al (2013) Organ involvement in Argentinian systemic sclerosis patients with “late” pattern as compared to patients with “early/active” pattern by nailfold capillaroscopy. Clin Rheumatol 32:839–843CrossRefPubMed
10.
go back to reference LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr et al (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15:202–205PubMed LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr et al (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15:202–205PubMed
11.
go back to reference Medsger TA Jr, Silman AJ, Steen VD, Black CM, Akesson A, Bacon PA et al (1999) A disease severity scale for systemic sclerosis: development and testing. J Rheumatol 26:2159–2167PubMed Medsger TA Jr, Silman AJ, Steen VD, Black CM, Akesson A, Bacon PA et al (1999) A disease severity scale for systemic sclerosis: development and testing. J Rheumatol 26:2159–2167PubMed
12.
go back to reference Geirsson AJ, Wollheim FA, Akesson A (2001) Disease severity of 100 patients with systemic sclerosis over a period of 14 years: using a modified Medsger scale. Ann Rheum Dis 60:1117–1122PubMedCentralCrossRefPubMed Geirsson AJ, Wollheim FA, Akesson A (2001) Disease severity of 100 patients with systemic sclerosis over a period of 14 years: using a modified Medsger scale. Ann Rheum Dis 60:1117–1122PubMedCentralCrossRefPubMed
13.
go back to reference Hudson M, Taillefer S, Steele R, Dunne J, Johnson SR, Jones N et al (2007) Improving the sensitivity of the American College of Rheumatology classification criteria for systemic sclerosis. Clin Exp Rheumatol 25:754–757PubMed Hudson M, Taillefer S, Steele R, Dunne J, Johnson SR, Jones N et al (2007) Improving the sensitivity of the American College of Rheumatology classification criteria for systemic sclerosis. Clin Exp Rheumatol 25:754–757PubMed
14.
go back to reference Smith V, Riccieri V, Pizzorni C, Decuman S, Deschepper E, Bonroy C et al (2013) Nailfold capillaroscopy for prediction of novel future severe organ involvement in systemic sclerosis. J Rheumatol 40:2023–2028CrossRefPubMed Smith V, Riccieri V, Pizzorni C, Decuman S, Deschepper E, Bonroy C et al (2013) Nailfold capillaroscopy for prediction of novel future severe organ involvement in systemic sclerosis. J Rheumatol 40:2023–2028CrossRefPubMed
15.
go back to reference Sambataro D, Sambataro G, Zaccara E, Maglione W, Polosa R, Afeltra AM et al (2014) Nailfold videocapillaroscopy micro-haemorrhage and giant capillary counting as an accurate approach for a steady state definition of disease activity in systemic sclerosis. Arthritis Res Ther 16:462PubMedCentralCrossRefPubMed Sambataro D, Sambataro G, Zaccara E, Maglione W, Polosa R, Afeltra AM et al (2014) Nailfold videocapillaroscopy micro-haemorrhage and giant capillary counting as an accurate approach for a steady state definition of disease activity in systemic sclerosis. Arthritis Res Ther 16:462PubMedCentralCrossRefPubMed
Metadata
Title
Assessment of nailfold capillaries with a handheld dermatoscope may discriminate the extent of organ involvement in patients with systemic sclerosis
Authors
Juan C. Arana-Ruiz
Luis H. Silveira
Diana Castillo-Martínez
Luis M. Amezcua-Guerra
Publication date
01-02-2016
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 2/2016
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-015-3112-x

Other articles of this Issue 2/2016

Clinical Rheumatology 2/2016 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.